Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized prime-boost pneumococcal vaccination study in adults with common variable immunodeficiency
2007-003235-23Phase 2Completed
- Sponsor
- Inserm
- Start
- Oct 2008
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal disease (2 arms), sponsored by Inserm. Started Oct 2008; status: completed.
02
Drugs
pneumococcal conjugate vaccine23-valent pneumococcal polysaccharide vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2007-003235-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003235-23.